Eli Lilly and (LLY)

AbbVie stock (NYSE: ABBV) rallied 11% in a week, largely driven by a key development that boosted the entire sector: Pfizer's agreement to lower its drug prices for Medicaid and a White House decision...

Normally when you think about earning big returns from the stock market, you're likely to remember risky investments that ended up paying off. But by no means is that the only case.

Novo Nordisk's and Eli Lilly's blockbuster weight-loss drugs should be the first medicines doctors reach for to treat obesity and its complications, a major European medical association advised on Thu...

Pharmaceutical concern Eli Lilly And Co  (NYSE:LLY ) is charging 7.2% higher to trade at $821.20 this afternoon.

The S&P 500, Dow, and Nasdaq were little changed Wednesday afternoon, as a federal government shutdown took effect.

Pfizer Inc's (NYSE:PFE) deal with Washington isn't just a handshake in the Oval Office — it's a seismic jolt to America's drug-pricing game. By agreeing to sell medicines on the government's new Trump...

Eli Lilly stock (NYSE: LLY) surged 5% yesterday, initially driven by news of a Pfizer deal with the White House to lower drug prices in exchange for tariff immunity. Following this, reports surfaced t...

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often ...

Apple (AAPL -0.43%) and Eli Lilly (LLY 0.12%) have faced significant volatility this year. However, both companies have benefited from recent positive developments, and their shares surged over the pa...